glp-1 launch Today marks the of the Medicare Bridge Program, giving eligible Medicare patients a new opportunity to access GLP-1 medications for weight management. The Medicare GLP-1 Bridge Program is intended for America Has a New GLP-1

FDA-approved indications Zepbound Adults with BMI 30 (obesity)

To make it work, they have to understand that its dosed slowly and low to mitigate the side effects, and that you really do have to be on a high-protein, low-calorie diet, you have to eat healthy, and you have to exercise, Apovian said

SGLT2 inhibitors during pregnancy Animal None of the SGLT2 inhibitors showed developmental toxicity when a dose not resulting in maternal toxicity was administered during the interval coinciding with the first trimester period of organogenesis except for canagliflozin, where ossification delays of the metatarsal bones were seen ( Table 2 )

cohort study, the 2-year discontinuation rate for GLP-1 receptor agonists was 64.1% among people with type 2 diabetes mellitus, driven by factors such as older age, low income, gastrointestinal adverse events, and insufficient weight loss [115]

That was, like, the main impetus of the lawsuit